Prospects for skin cancer treatment and prevention: the potential contribution of an engineered virus

Related Experiment Video

Updated: Jun 4, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Jennifer A Cafardi1, Rubina Shafi, Mohammad Athar

  • 1Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

The Journal of Investigative Dermatology
|February 11, 2011
PubMed

Insights

Scientists engineered a virus-derived enzyme to remove UVB-induced DNA damage in skin. This DNA repair enzyme shows promise for preventing and treating skin cancers.

Area of Science:

  • Molecular Biology
  • Dermatology
  • Biochemistry

Background:

  • Nonmelanoma skin cancers are common malignancies linked to solar UVB radiation.
  • UVB exposure causes DNA lesions like cyclobutane pyrimidine dimers and 6-4 photoproducts.
  • Human cells primarily use nucleotide excision repair for these lesions due to a lack of specific DNA glycosylases.

Discussion:

  • Johnson et al. engineered a Chlorella virus DNA glycosylase for enhanced tissue penetration and nuclear localization.
  • This modified enzyme effectively removed UVB-induced DNA lesions in a human skin equivalent model.
  • The study demonstrates the potential of this enzyme in a topical formulation for skin damage treatment.

Key Insights:

  • A virus-derived DNA glycosylase can repair UVB-induced DNA damage in human skin models.
  • Engineered enzyme exhibits improved tissue penetration and nuclear targeting.
  • Topical application of the enzyme is feasible for preventing and treating DNA damage.

Outlook:

  • This enzyme could be integrated into chemoprevention strategies for skin cancers.
  • Further research may explore its efficacy and safety in clinical settings.
  • Potential for novel therapeutic approaches to mitigate UV-induced skin damage.

More Related Videos

Ex Vivo Infection of Live Tissue with Oncolytic Viruses12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.